EUVIMEDEUVIMED entdecken
Netzwerk-Metaanalyse

Dose-Level Efficacy and Safety of Oveporexton and TAK-994 for Narcolepsy Type 1: A Network Meta-Analysis

Waqas Kareem, Beesham Kumar Lohana, Rahul Rai, Kapeel Kumar, Fizza Hanif, Afshan Jabeen, Mahroz Khan, Mediha Farooq, Aderinsola Wale-Oyedele, Payal Devi, Hira Riaz

Journal of Pharmacy and Pharmacology Research · 2026

DOI: 10.26502/fjppr.0131 ↗

Kurz gefasst

Netzwerk-Metaanalyse in der Zeitschrift Journal of Pharmacy and Pharmacology Research, 2026. Verfasst von Waqas Kareem und 10 weiteren Autor:innen.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Zitieren

APA

Kareem, W., Lohana, B. K., Rai, R., Kumar, K., Hanif, F., Jabeen, A., Khan, M., Farooq, M., Wale-Oyedele, A., Devi, P., & Riaz, H. (2026). Dose-Level Efficacy and Safety of Oveporexton and TAK-994 for Narcolepsy Type 1: A Network Meta-Analysis. Journal of Pharmacy and Pharmacology Research. https://doi.org/10.26502/fjppr.0131

Vancouver

Kareem W, Lohana BK, Rai R, Kumar K, Hanif F, Jabeen A, et al. Dose-Level Efficacy and Safety of Oveporexton and TAK-994 for Narcolepsy Type 1: A Network Meta-Analysis. Journal of Pharmacy and Pharmacology Research. 2026. doi:10.26502/fjppr.0131

BibTeX
@article{Kareem2026,
  author = {Kareem, Waqas and Lohana, Beesham Kumar and Rai, Rahul and Kumar, Kapeel and Hanif, Fizza and Jabeen, Afshan and Khan, Mahroz and Farooq, Mediha and Wale-Oyedele, Aderinsola and Devi, Payal and Riaz, Hira},
  title = {Dose-Level Efficacy and Safety of Oveporexton and TAK-994 for Narcolepsy Type 1: A Network Meta-Analysis},
  journal = {Journal of Pharmacy and Pharmacology Research},
  year = {2026},
  doi = {10.26502/fjppr.0131}
}
Kostenlos starten →